Pages that link to "Q61466188"
Jump to navigation
Jump to search
The following pages link to Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL (Q61466188):
Displaying 26 items.
- Tumor masses support naive T cell infiltration, activation, and differentiation into effectors (Q30433292) (← links)
- All in the head: obstacles for immune rejection of brain tumours (Q34842204) (← links)
- Heterogeneity of CD4(+) and CD8(+) T cells (Q35145793) (← links)
- Strong spontaneous tumor neoantigen responses induced by a natural human carcinogen (Q35799065) (← links)
- Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. (Q35835489) (← links)
- CD4 cells can be more efficient at tumor rejection than CD8 cells (Q35839925) (← links)
- A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy. (Q36613715) (← links)
- Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression (Q37486804) (← links)
- A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses (Q37585518) (← links)
- Cross-priming in health and disease. (Q37760422) (← links)
- Harnessing the immune response to treat cancer (Q37790599) (← links)
- Contribution of the immune system to the chemotherapeutic response. (Q37832967) (← links)
- A review of the importance of immune responses in luminal B breast cancer. (Q39239484) (← links)
- CD8+ T cell-independent tumor regression induced by Fc-OX40L and therapeutic vaccination in a mouse model of glioma. (Q39303777) (← links)
- In vivo depletion of DC impairs the anti-tumor effect of agonistic anti-CD137 mAb. (Q39815528) (← links)
- An allogeneic hybrid-cell fusion vaccine against canine mammary cancer (Q39990608) (← links)
- The immune anti-tumor effects of GM-CSF and B7-1 gene transfection are enhanced by surgical debulking of tumor (Q40684807) (← links)
- Spontaneous CD4+ and CD8+ T-cell responses directed against cancer testis antigens are present in the peripheral blood of testicular cancer patients (Q41077105) (← links)
- Turning the tumor microenvironment into a self vaccine site. (Q41474502) (← links)
- ISCOM based vaccines for cancer immunotherapy (Q44908815) (← links)
- Dendritic cells infected with a vaccinia virus interleukin-2 vector secrete high levels of IL-2 and can become efficient antigen presenting cells that secrete high levels of the immunostimulatory cytokine IL-12. (Q45722523) (← links)
- Immunostimulatory cancer chemotherapy using local ingenol-3-angelate and synergy with immunotherapies (Q47840657) (← links)
- Cutting Edge: CD8+ Effector T Cells Reject Tumors by Direct Antigen Recognition but Indirect Action on Host Cells (Q73299715) (← links)
- A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice (Q90098354) (← links)
- Neo-antigen specific T cell responses indicate the presence of metastases before imaging (Q90641351) (← links)
- Cytotoxic Chemotherapy as an Immune Stimulus: A Molecular Perspective on Turning Up the Immunological Heat on Cancer (Q92405012) (← links)